Josh Arnold Investment Consultant LLC Takes Position in Teleflex Incorporated $TFX

Posted by on Jun 19th, 2026

Josh Arnold Investment Consultant LLC purchased a new position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 265,000 shares of the medical technology company’s stock, valued at approximately $32,341,000. Teleflex accounts for about 17.7% of Josh Arnold Investment Consultant LLC’s portfolio, making the stock its 2nd largest position. Josh Arnold Investment Consultant LLC owned approximately 0.60% of Teleflex as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in TFX. Banque Cantonale Vaudoise increased its stake in Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after acquiring an additional 113 shares during the last quarter. V Square Quantitative Management LLC bought a new stake in Teleflex during the fourth quarter worth $37,000. UMB Bank n.a. increased its stake in shares of Teleflex by 57.1% in the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after buying an additional 113 shares during the period. Sound Income Strategies LLC acquired a new stake in Teleflex during the 4th quarter valued at approximately $45,000. Finally, Kestra Advisory Services LLC bought a new position in Teleflex during the 4th quarter worth approximately $45,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of NYSE TFX opened at $126.97 on Friday. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $139.67. The stock has a market cap of $5.62 billion, a price-to-earnings ratio of -5.57, a PEG ratio of 0.93 and a beta of 0.82. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. The firm’s 50-day simple moving average is $129.54 and its 200 day simple moving average is $119.33.

Teleflex (NYSE:TFX – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The firm had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company’s revenue for the quarter was up 32.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, research analysts anticipate that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be issued a dividend of $0.34 per share. The ex-dividend date is Friday, May 22nd. This represents a $1.36 annualized dividend and a yield of 1.1%. Teleflex’s dividend payout ratio is -5.96%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on TFX. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research note on Friday, March 27th. Royal Bank Of Canada upgraded shares of Teleflex from a “sector perform” rating to an “outperform” rating and boosted their target price for the company from $135.00 to $155.00 in a report on Friday, May 8th. Truist Financial reaffirmed a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Needham & Company LLC increased their price target on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. Finally, Mizuho set a $140.00 price objective on Teleflex in a research report on Friday, May 8th. Four research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $146.00.

Check Out Our Latest Analysis on Teleflex

Teleflex Profile

(Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Featured Stories

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.